Conventional immunoassay techniques requiring long washing, precipitation, scintillation counting or other complex steps have largely been supplanted in target drug evaluation by homogeneous, single step assays. This fast, preliminary analysis or High Throughput Screening (HTS) has the potential to identify the most promising chemical entities among tens of thousands of candidate compounds.
However, if the HTS method sacrifices sensitivity or accuracy in the pursuit of speed, much of its promise is wasted.
Cayman's HTS assays are built to meet the standards required by the HTS community including
The result is that we offer high-quality assays that are often a fraction of the cost per well of a conventional assay—for example, the PGE2 FPIA - Green is only 0,59 € per well in a 384-well format.
Cayman currently offers Fluorescence Polarization Immunoassays (FPIAs) for the measurement of Prostaglandin E2 and Prostaglandin D2 which are based on either fluorescein ("Green") or rhodamine ("Red") fluorophores. In addition, a novel FP-based assay for hematopoietic-type Prostaglandin D Synthase is now available.
Please contact Cayman Chemical's sales or technical staff to see how these assays fit into your current or future drug screening campaign.
| Class | Rhodamine "Red" | Fluorescein "Green" | Non-FPIA counterpart |
|---|---|---|---|
|
Prostaglandin E2
|
Prostaglandin E2 FPIA Kit - Red
|
Prostaglandin E2 FPIA Kit - Green
|
Prostaglandin E2 EIA Kit - Monoclonal
|
|
Prostaglandin D2
|
$product.getDisplayName()
|
Cayman’s H-PGDS FP-Based Inhibitor Screening Assay Kit - Green provides a rapid, accurate assay for screening H-PGDS inhibitors. The novel technology in this assay eliminates the need for using the highly unstable substrate PGH2. Rather, a H-PGDS inhibitor-fluorescein conjugate serves as a specific fluorescent probe for the enzyme. Displacement of the probe by any unlabeled H-PGDS inhibitor leads to a decrease in the fluorescence polarization (FP) state of the probe, providing a direct signal for binding of the inhibitor to the active site of the enzyme.
Cayman Chemical offers a unique set of compound libraries, rich in biologically active molecules, useful for screening and hit-seeking for diverse therapeutic targets.